A Canadian Laboratory‐Based Retrospective of the 2024/2025 Influenza Season: Monitoring the Impacts of Influenza Evolution on Viral Antigenicity and Antiviral Susceptibility
Influenza and Other Respiratory Viruses · 2026-11 · 20 (11)
DOI: 10.1111/irv.70359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, online erschienen am 16.11.2026. Verfasst von Charlene Ranadheera und 18 weiteren Autor:innen. Beteiligte Einrichtung: Influenza, Respiratory Viruses, and Coronaviruses, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canad…. Hauptthemen laut MEDLINE: Influenza, Human, Antiviral Agents, Influenza B virus, Antigens, Viral. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Seasonal influenza affects thousands of Canadians each year and places significant strain on workplaces and the health systems. Robust laboratory‐based surveillance is essential to monitor viral evolution and evaluate the suitability of medical countermeasures.
Methods
The Canadian Influenza Surveillance Program characterizes circulating influenza viruses to determine genetic clades, monitor evolutionary trends, assess antigenicity and vaccine strain relatedness, and evaluate susceptibility to neuraminidase inhibitors. Methods include whole genome sequencing, hemagglutination inhibition assays, and neuraminidase inhibition assays.
Results
From September 1, 2024 to August 31, 2025, the program antigenically characterized 1563 influenza isolates identified and submitted by Canadian laboratories. Of these, 99.4% of influenza A/H1N1, 86.6% of influenza A/H3N2, and 100% of influenza B isolates were antigenically related to their respective component of the 2024–2025 Northern Hemisphere vaccine. Genetic analysis of influenza A/H3N2 isolates identified three distinct mutation clustering patterns associated with reduced antigenic reactivity to the vaccine strain. Additionally, 1567 influenza viruses underwent antiviral susceptibility testing. Eleven influenza A/H1N1 isolates showed reduced inhibition to oseltamivir and two to zanamivir, all containing known resistance‐associated markers.
Conclusions
These findings highlight the importance of comprehensive virological assessment, integrating genotypic and phenotypic data, to inform annual vaccine strain selection and support clinical decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Influenza, Respiratory Viruses, and Coronaviruses, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
- British Columbia Centre for Disease Control Public Health Laboratory, Provincial Health Services Authority, Vancouver, British Columbia, Canada.
- Roy Romanow Provincial Laboratory, Saskatchewan Health Authority, Regina, Saskatchewan, Canada.
- Cadham Provincial Public Health Laboratory, Winnipeg, Manitoba, Canada.
- Public Health Ontario, Microbiology and Laboratory Services, Toronto, Ontario, Canada.
- Institut national de santé publique du Québec, Québec, Canada.
ORCID-Profile: Charlene Ranadheera, Ruimin Gao, Cody Buchanan, Maan Hasso, Robert Needle, Taeyo Chestley
Zitieren
APA
Ranadheera, C., Gao, R., Buchanan, C., Frost, J., Jassem, A., Lang, A., Minion, J., Dust, K., Van Caseele, P., Hasso, M., Meunier, I., Garceau, R., Desnoyers, G., Simms, E., Arseneau, V., Jiao, L., Needle, R., Chestley, T., & Bastien, N. (2026). A Canadian Laboratory‐Based Retrospective of the 2024/2025 Influenza Season: Monitoring the Impacts of Influenza Evolution on Viral Antigenicity and Antiviral Susceptibility. Influenza and Other Respiratory Viruses, 20(11). https://doi.org/10.1111/irv.70359
Vancouver
Ranadheera C, Gao R, Buchanan C, Frost J, Jassem A, Lang A, et al. A Canadian Laboratory‐Based Retrospective of the 2024/2025 Influenza Season: Monitoring the Impacts of Influenza Evolution on Viral Antigenicity and Antiviral Susceptibility. Influenza and Other Respiratory Viruses. 2026;20(11). doi:10.1111/irv.70359
BibTeX
@article{Ranadheera2026,
author = {Ranadheera, Charlene and Gao, Ruimin and Buchanan, Cody and Frost, Jasmine and Jassem, Agatha and Lang, Amanda and Minion, Jessica and Dust, Kerry and Van Caseele, Paul and Hasso, Maan and Meunier, Isabelle and Garceau, Richard and Desnoyers, Guillaume and Simms, Elizabeth and Arseneau, Vannesa and Jiao, Lei and Needle, Robert and Chestley, Taeyo and Bastien, Nathalie},
title = {A Canadian Laboratory‐Based Retrospective of the 2024/2025 Influenza Season: Monitoring the Impacts of Influenza Evolution on Viral Antigenicity and Antiviral Susceptibility},
journal = {Influenza and Other Respiratory Viruses},
year = {2026},
volume = {20},
number = {11},
doi = {10.1111/irv.70359}
}
EUVIMED